← Leaderboards
Stephen Magura
National Development &Res Institutes
$17,620,705
Attributed
$17,620,705
Total exposure
13
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$17,620,705 · 13
By mechanism
R01$16,429,785 · 10
R21$1,190,920 · 3
Top collaborators
No co-investigators on record.
Most similar at National Development &Res Institutes
Same institution · by research overlap
- Alexandre B Laudet$4,872,585
- Sherry Deren$12,460,666
- Gregory P Falkin$13,136,052
- Michael C. Clatts$12,748,372
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchBehavioral /Social Science Research TagHuman SubjectLongitudinal Human StudyProgramsMotivationHuman Therapy EvaluationClinical TrialsTherapy ComplianceDrug Abuse TherapyGroup TherapySocial ModelModel Design /DevelopmentPharmaceutical PreparationsHealth Services Research TagBehavior TherapyMethadoneInterviewHealth BehaviorDrug AbuseHiv InfectionsMental DisordersCost EffectivenessLead
Grant awards (40)
Advancing the Use of Oral Fluid to Monitor Therapeutic and Illicit Drugs in Outpatient Clinical and Field Settings$720,974
R01 · FY2020 · DA · contact PI
Advancing the Use of Oral Fluid to Monitor Therapeutic and Illicit Drugs in Outpatient Clinical and Field Settings$128,806
R01 · FY2020 · DA · contact PI
Advancing the Use of Oral Fluid to Monitor Therapeutic and Illicit Drugs in Outpatient Clinical and Field Settings$726,361
R01 · FY2019 · DA · contact PI
Community Utilization of Evidence-Based Program Registers in Behavioral Healthcare$684,655
R01 · FY2019 · DA · contact PI
Community Utilization of Evidence-Based Program Registers in Behavioral Healthcare$701,729
R01 · FY2018 · DA · contact PI
Community Utilization of Evidence-Based Program Registers in Behavioral Healthcare$742,455
R01 · FY2017 · DA · contact PI
Critical Review of Evidence-Based Program Repositories for Behavioral Health Trea$186,250
R21 · FY2012 · DA · contact PI
Efficacy of "Dual Focus" Mutual Aid for Persons with Co-occurring Disorders$417,727
R01 · FY2011 · DA · contact PI
Critical Review of Evidence-Based Program Repositories for Behavioral Health Trea$223,500
R21 · FY2011 · DA · contact PI
Efficacy of "Dual Focus" Mutual Aid for Persons with Co-occurring Disorders$476,874
R01 · FY2010 · DA · contact PI
Controlling for Endogeneity Biases in Estimating AA Effects on Drinking Outcomes$146,520
R21 · FY2010 · AA · contact PI
Efficacy of "Dual Focus" Mutual Aid for Persons with Co-occurring Disorders$480,840
R01 · FY2009 · DA · contact PI
Controlling for Endogeneity Biases in Estimating AA Effects on Drinking Outcomes$259,000
R21 · FY2009 · AA · contact PI
Efficacy of "Dual Focus" Mutual Aid for Persons with Co-occurring Disorders$492,665
R01 · FY2008 · DA · contact PI
Buprenorphine Maintenance for Opioid Addicted Persons in Jail and Post-Release$202,156
R21 · FY2007 · DA · contact PI
Buprenorphine Maintenance for Opioid Addicted Persons in Jail and Post-Release$173,494
R21 · FY2006 · DA · contact PI
Control Trial of Self-Help for Dually-Diagnosed Persons$426,028
R01 · FY2005 · DA
Control Trial of Self-Help for Dually-Diagnosed Persons$611,617
R01 · FY2004 · DA
INNOVATIVE JOB PLACEMENT MODEL FOR METHADONE PATIENTS$543,807
R01 · FY2004 · DA
Control Trial of Self-Help for Dually-Diagnosed Persons$594,580
R01 · FY2003 · DA
PEER MENTORS FOR ADOLESCENTS IN HIV-AFFECTED FAMILIES$536,584
R01 · FY2003 · HD
INNOVATIVE JOB PLACEMENT MODEL FOR METHADONE PATIENTS$533,651
R01 · FY2003 · DA
SERVICE OUTREACH TO HOMELESS DRUG USERS$127,602
R01 · FY2003 · DA
PEER MENTORS FOR ADOLESCENTS IN HIV-AFFECTED FAMILIES$651,524
R01 · FY2002 · HD
SERVICE OUTREACH TO HOMELESS DRUG USERS$583,745
R01 · FY2002 · DA
INNOVATIVE JOB PLACEMENT MODEL FOR METHADONE PATIENTS$563,854
R01 · FY2002 · DA
Trial of Self-Help Groups for Dually-Diagnosed Persons$557,274
R01 · FY2002 · DA
GROUP MOTIVATIONAL INTERVENTION IN DRUG ABUSE TREATMENT$293,842
R01 · FY2002 · DA
SERVICE OUTREACH TO HOMELESS DRUG USERS$230,528
R01 · FY2002 · DA
INNOVATIVE JOB PLACEMENT MODEL FOR METHADONE PATIENTS$43,231
R01 · FY2002 · DA
LEVELS OF CARE AND OUTCOMES IN ALCOHOLISM TREATMENT$17,967
R01 · FY2002 · AA
PEER MENTORS FOR ADOLESCENTS IN HIV-AFFECTED FAMILIES$646,562
R01 · FY2001 · HD
SERVICE OUTREACH TO HOMELESS DRUG USERS$600,736
R01 · FY2001 · DA
INNOVATIVE JOB PLACEMENT MODEL FOR METHADONE PATIENTS$548,774
R01 · FY2001 · DA
GROUP MOTIVATIONAL INTERVENTION IN DRUG ABUSE TREATMENT$441,836
R01 · FY2001 · DA
PEER MENTORS FOR ADOLESCENTS IN HIV-AFFECTED FAMILIES$631,806
R01 · FY2000 · HD
INNOVATIVE JOB PLACEMENT MODEL FOR METHADONE PATIENTS$575,060
R01 · FY2000 · DA
SERVICE OUTREACH TO HOMELESS DRUG USERS$544,660
R01 · FY2000 · DA
GROUP MOTIVATIONAL INTERVENTION IN DRUG ABUSE TREATMENT$404,154
R01 · FY2000 · DA
EFFECTIVENESS OF SELF HELP FOR THE DUALLY DIAGNOSED$147,277
R01 · FY2000 · DA